| 1 |
Guidance Document for Functions and Responsibilities of Zonal, Sub-Zonal and Port offices of CDSCO |
2024-Sep-12 |
|
16016 KB |
| 2 |
Guidance for Export NOC for Manufacture of Unapproved / Banned / New Drugs along with Annexures |
2024-Jul-03 |
|
1352 KB |
| 3 |
PAC Guidance for Biological Products - Quality Safety and Efficacy Document Version 1.2 |
2024-May-16 |
|
14186 KB |
| 4 |
CDSCO Guidance for Industry Version 1.2 Biologicals |
2024-May-15 |
|
1214 KB |
| 5 |
Guidance document on Stability Studies of In-Vitro Diagnostic Medical Device (IVDMD) |
2024-Apr-05 |
|
490 KB |
| 6 |
Guidance Document on Risk Based Approach for Monitoring Quality at the Ports of Import |
2024-Apr-02 |
|
1067 KB |
| 7 |
Guidance document on procedures to be followed For Evaluation of applications By The subject expert committees |
2024-Apr-02 |
|
430 KB |
| 8 |
Guidelines on good distribution practices for pharmaceutical Products |
2024-Apr-02 |
|
783 KB |
| 9 |
Policy on Vaccine Approval |
2024-Apr-02 |
|
390 KB |
| 10 |
Good Clinical Practice Guidelines |
2017-Feb-17 |
|
1074 KB |
